NIH-funded research R01 grant

How the cell 'cleanup' system (ubiquitin) affects corneal scarring

Official title: THE UBIQUITIN PATHWAY IN CORNEAL SCARRING

Funded at Upstate Medical University · NIH-11285136 · Data updated 2026-11-12

This work looks at whether blocking a protein called USP10 can reduce scarring after cornea injury to help protect or restore vision.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUpstate Medical University
NIH-funded
Lab location1 site (Syracuse, United States)
Project startAugust 1, 2015
Project endJanuary 31, 2027
Funding year2026
Award (this year)$366,750
NIH project number5R01EY024942-08
Project IDNIH-11285136 on NIH RePORTER

Who could benefit from this research

Could help

People who have had recent corneal injury, infection, surgery, or who are developing corneal scarring would be the most relevant candidates to engage with related studies or sample donation.

Less likely to help

Patients with unrelated eye problems or very old, stable corneal scars that are unlikely to remodel may not see direct benefit from this line of work in the short term.

What this research studies

Researchers are exploring a cellular system called ubiquitin and a key protein, USP10, that seems to drive scarring in the cornea. They use donated primary human corneal cells and mouse models to see how USP10 controls cell behavior and survival through proteins like integrins and p53. The team is also growing corneal cells with immune cells on 3D hydrogels that mimic the healing cornea to study how macrophages influence scar-forming myofibroblasts. Findings could point to ways to limit harmful scarring after injury or infection.

Why it matters

Potential benefit: If successful, this work could lead to treatments that reduce corneal scarring and lower the risk of permanent vision loss after injury or infection.

How similar studies have gone: Early lab and animal work (including the investigators' own mouse studies) shows that reducing USP10 can lessen scarring, but human treatments based on this approach have not yet been developed.

Where this research is happening

  • Upstate Medical University
    Syracuse, United States
    Active

Researchers

  • Principal investigator: Bernstein, Audrey M — Upstate Medical University
  • Study coordinator: Bernstein, Audrey M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.